Invention Grant
US08227581B2 Modified α-galactosyl ceramides for staining and stimulating natural killer T cells
有权
改良的α-半乳糖神经酰胺用于染色和刺激天然杀伤T细胞
- Patent Title: Modified α-galactosyl ceramides for staining and stimulating natural killer T cells
- Patent Title (中): 改良的α-半乳糖神经酰胺用于染色和刺激天然杀伤T细胞
-
Application No.: US12296169Application Date: 2007-04-09
-
Publication No.: US08227581B2Publication Date: 2012-07-24
- Inventor: Paul B. Savage , Luc Teyton , Albert Bendelac
- Applicant: Paul B. Savage , Luc Teyton , Albert Bendelac
- Applicant Address: US CA La Jolla US IL Chicago US UT Provo
- Assignee: The Scripps Research Institute,The University of Chicago,Brigham Young University
- Current Assignee: The Scripps Research Institute,The University of Chicago,Brigham Young University
- Current Assignee Address: US CA La Jolla US IL Chicago US UT Provo
- Agency: Merchant & Gould P.C.
- International Application: PCT/US2007/066250 WO 20070409
- International Announcement: WO2007/118234 WO 20071018
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/7028 ; A61K38/17 ; C07H15/04
Abstract:
Modified glycolipid compounds are provided. Also disclosed are methods for activating an NKT cell, methods of stimulating an immune response in a subject, and methods suitable for labeling NKT cells.
Public/Granted literature
- US20090047299A1 MODIFIED ALPHA-GALACTOSYL CERAMIDES FOR STAINING AND STIMULATING NATURAL KILLER T CELLS Public/Granted day:2009-02-19
Information query
